• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: UNKNOWN PERITONEAL DIALYSIS CATHETER; CATHETER, PERITONEAL, LONG-TERM INDWELLING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

UNKNOWN PERITONEAL DIALYSIS CATHETER; CATHETER, PERITONEAL, LONG-TERM INDWELLING Back to Search Results
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Chest Pain (1776); Peritonitis (2252); Abdominal Distention (2601)
Event Date 05/12/2022
Event Type  Injury  
Event Description
It was reported that on (b)(6)2022, a peritoneal dialysis registered nurse [(pd}rn] reported to fresenius technical services this pd patient on continuous cyclic pd (ccpd} therapy on the liberty select cycler experienced peritonitis.There was no specific allegation this adverse event was due to a deficiency or malfunction of any fresenius product(s} or device(s} in the initial reporting.Upon follow up with the patient's pdrn, it was reported this patient was admitted to the hospital for chest pain on (b)(6)2022.There was no indication the patient's chest pain was related to the peritonitis event, the performance of any fresenius product(s} or device(s} or pd therapy in general.The patient experienced abdominal bloating during ccpd therapy on the liberty select cycler prior to this admission.Peritoneal effluent fluid cultures taken in the hospital on (b)(6)2022 presented with streptococcus mitis and a white blood cell (wbc) count of 22,889/mm3.The patient was diagnosed with peritonitis due to inappropriate infection control during pd therapy.It was explained the patient ran out of alcavis wipes to clean his catheter during pd therapy and alternatively, was using an inappropriate cleaning agent.The patient was prescribed intraperitoneal (ip} diflucan at 200 mg daily for three weeks and ip ceftazidime at 2000 mg daily for three weeks.The patient was able to undergo ccpd therapy on a hospital provided cycler (unknown brand and model} for the duration of the admission.The patient recovered from this event and was discharged to home on (b)(6)2022.It was confirmed the patient's peritonitis, and the associated hospitalization were not due to a deficiency or malfunction of any fresenius product(s} or device(s}.Follow up peritoneal effluent fluid cultures taken in the outpatient clinic on (b)(6)2022 presented no growth, evidencing a resolved infection.The patient continues ccpd therapy on the same liberty select cycler at home post-discharge with persisting drain complications.The patient is scheduled for a pd catheter (not a fresenius product} evaluation as his catheter is the suspected cause of drain complications.(b)(4).This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERITONEAL DIALYSIS CATHETER
Type of Device
CATHETER, PERITONEAL, LONG-TERM INDWELLING
Manufacturer (Section D)
UNKNOWN
MDR Report Key17527927
MDR Text Key321146862
Report NumberMW5134858
Device Sequence Number1
Product Code FJS
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial
Report Date 05/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/12/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Patient Sequence Number1
-
-